|
Mammary Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
"c-erbB-2 and the ""triple-state"" in early breast carcinomas."
|
19548127 |
2010 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
"c-erbB-2 and the ""triple-state"" in early breast carcinomas."
|
19548127 |
2010 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment.
|
17415682 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
AKT regulation of estrogen receptor beta transcriptional activity in breast cancer.
|
16951146 |
2006 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Apigenin suppresses cancer cell growth through ERbeta.
|
17132221 |
2006 |
|
Mammary Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
Apigenin suppresses cancer cell growth through ERbeta.
|
17132221 |
2006 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
|
17640362 |
2007 |
|
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
|
17904846 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
By Western blot analysis, we show that ER-beta protein is expressed in all cancer cell lines tested and in three of five breast tumor samples.
|
10554010 |
1999 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
|
18669459 |
2008 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.
|
16791593 |
2006 |
|
Mammary Neoplasms
|
0.400 |
PosttranslationalModification
|
group |
LHGDN |
CpG methylation of the ERalpha and ERbeta genes in breast cancer.
|
15254780 |
2004 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.
|
18216219 |
2008 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
|
14715875 |
2004 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
ERbeta exerts multiple stimulative effects on human breast carcinoma cells.
|
15208676 |
2004 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
|
15383631 |
2004 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins.
|
17604135 |
2007 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
|
15355905 |
2004 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer.
|
16261413 |
2005 |
|
Mammary Neoplasms
|
0.400 |
Therapeutic
|
group |
CTD_human |
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
|
19434490 |
2010 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
|
19434490 |
2010 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.
|
14745018 |
2004 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Estrogen receptor-beta: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer?
|
17617929 |
2007 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
|
18234277 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
|
10601611 |
2000 |